DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gralla R. et al.
Lung Cancer Symptom Scale (LCSS) as a marker of treatment (tx) benefit with nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC from CheckMate 057.
J Clin Oncol; 2016
34. (suppl; abstr 9031)
Access:
We do not assume any responsibility for the contents of the web pages of other providers.